Glycopegylated erythropoietin

Details for Australian Patent Application No. 2004293103 (hide)

International Classifications

Event Publications

1 June 2006 PCT application entered the National Phase

PCT publication WO2005/051327 Priority application(s): WO2005/051327

23 April 2009 Assignment before Grant

Neose Technologies, Inc. The application has been assigned to BioGeneriX AG

24 June 2010 Application Accepted

Published as AU-B-2004293103

12 August 2010 Application for Amendment

The nature of the amendment is as shown in the statement(s) filed 22 Jul 2010. Address for service in Australia - Allens Arthur Robinson Patent & Trade Marks Attorneys Deutsche Bank Place Corner Hunter and Phillip Street Sydney NSW 2000

2 December 2010 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 22 Jul 2010 2005

9 December 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.